GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Tesla (NASDAQ: TSLA) stock fell 6.5%, adding to the more than 40% losses in 2025, as the EV manufacturer’s supply chain faces ...

The tariffs are here but so are the deals – check out these great 0% financing offers on new plug-in cars good through April ...

Fluor Corporation offers strong growth catalysts in energy and data centers but faces recent earnings downgrades. See why FLR ...

After a scoreless first half, an Emmanuel Sandoval goal in the opening minutes of the final 40 would be all the offense ...

It’s one of the first three concepts from General Motors to be shown in 2025 as part of a Corvette design project.

Piyush Goyal, the usually affable union minister of commerce and industry, has stirred a hornet’s nest with his comments ...

"Spa Bahar" – A Private and Luxurious Spa Experience in Givat Ze’ev In Givat Ze’ev, near Jerusalem, lies "Spa Bahar," a ...

Learn more about whether Alvotech or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

First, the formalities. While this striking concept might wear a Corvette badge (or a slick new minimalist reimagining of it) ...

Analysts tracking the company predict a 17.71% year-over-year growth in its adjusted EPS to $1.13 for fiscal 2025. Moreover, ...